awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38206551-323CBC9E-A8DD-4CCF-B4A5-B626CAEE9991
Q38206551-323CBC9E-A8DD-4CCF-B4A5-B626CAEE9991
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38206551-323CBC9E-A8DD-4CCF-B4A5-B626CAEE9991
Investigational drugs for treating psoriatic arthritis.
P2860
Q38206551-323CBC9E-A8DD-4CCF-B4A5-B626CAEE9991
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38206551-323CBC9E-A8DD-4CCF-B4A5-B626CAEE9991
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ecb800be8cbc74456453db61e780ac4b93d90a1c
P2860
A phase 2 dose-ranging study of subcutaneous tabalumab for the treatment of patients with active rheumatoid arthritis and an inadequate response to methotrexate.